SG10201914102UA - Stem cells for wound healing - Google Patents

Stem cells for wound healing

Info

Publication number
SG10201914102UA
SG10201914102UA SG10201914102UA SG10201914102UA SG10201914102UA SG 10201914102U A SG10201914102U A SG 10201914102UA SG 10201914102U A SG10201914102U A SG 10201914102UA SG 10201914102U A SG10201914102U A SG 10201914102UA SG 10201914102U A SG10201914102U A SG 10201914102UA
Authority
SG
Singapore
Prior art keywords
stem cells
wound healing
healing
wound
stem
Prior art date
Application number
SG10201914102UA
Inventor
Aernout Luttun
Robert Deans
Original Assignee
Abt Holding Co
Univ Leuven Kath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abt Holding Co, Univ Leuven Kath filed Critical Abt Holding Co
Publication of SG10201914102UA publication Critical patent/SG10201914102UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/12—Animals modified by administration of exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
SG10201914102UA 2016-01-21 2016-02-12 Stem cells for wound healing SG10201914102UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662281334P 2016-01-21 2016-01-21

Publications (1)

Publication Number Publication Date
SG10201914102UA true SG10201914102UA (en) 2020-03-30

Family

ID=59360064

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201914102UA SG10201914102UA (en) 2016-01-21 2016-02-12 Stem cells for wound healing
SG11201806245TA SG11201806245TA (en) 2016-01-21 2016-02-12 Stem cells for wound healing

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201806245TA SG11201806245TA (en) 2016-01-21 2016-02-12 Stem cells for wound healing

Country Status (11)

Country Link
US (2) US10967006B2 (en)
EP (1) EP3405566B1 (en)
JP (3) JP6918003B2 (en)
KR (1) KR20180102661A (en)
CN (1) CN108884437A (en)
AU (2) AU2016387339B2 (en)
CA (1) CA3012330A1 (en)
HK (1) HK1256413A1 (en)
NZ (1) NZ745530A (en)
SG (2) SG10201914102UA (en)
WO (1) WO2017127123A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201913920PA (en) 2010-05-12 2020-03-30 Abt Holding Co Modulation of splenocytes in cell therapy
EP3795159A1 (en) 2013-04-12 2021-03-24 Houston Methodist Hospital Improving organs for transplantation
KR20180102661A (en) * 2016-01-21 2018-09-17 에이비티 홀딩 컴퍼니 Stem cells for wound healing
WO2019059741A1 (en) * 2017-09-25 2019-03-28 사회복지법인 삼성생명공익재단 Stem cell dosage formulation containing cerebrospinal fluid and method for producing same

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US7037721B1 (en) 1990-01-29 2006-05-02 Hy-Gene Biomedical, Inc. Protein-free defined media for the growth of normal human keratinocytes
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
AU2882992A (en) 1991-11-06 1993-06-07 Arthur A. Axelrad Cell culture medium
WO1994000484A1 (en) 1992-06-22 1994-01-06 Young Henry E Scar inhibitory factor and use thereof
US5766951A (en) 1992-11-12 1998-06-16 Quality Biological, Inc. Serum-free medium supporting growth and proliferation of normal bone marrow cells
US6037174A (en) 1993-08-23 2000-03-14 Nexell Therapeutics, Inc. Preparation of serum-free suspensions of human hematopoietic cells or precursor cells
US5409813A (en) 1993-09-30 1995-04-25 Systemix, Inc. Method for mammalian cell separation from a mixture of cell populations
GB9502022D0 (en) 1995-02-02 1995-03-22 Abuljadayel Ilham M S A method for preparing lymphohaematopoietic progenitor cells
US5906934A (en) 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
US6653134B2 (en) 1995-03-28 2003-11-25 Cp Hahnemann University Isolated stromal cells for use in the treatment of diseases of the central nervous system
US5908782A (en) 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
US5945337A (en) 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
AU7984498A (en) 1997-06-25 1999-01-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Serum-free cell growth medium
US6077987A (en) 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration
WO2000027996A1 (en) 1998-11-09 2000-05-18 Consorzio Per La Gestione Del Centro Di Biotecnologie Avanzate Serum free medium for chondrocyte-like cells
US6777231B1 (en) 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20050169896A1 (en) 1999-05-14 2005-08-04 Henry Ford Health System Bone marrow transplantation for treatment of stroke
US10638734B2 (en) 2004-01-05 2020-05-05 Abt Holding Company Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US8147824B2 (en) 1999-08-05 2012-04-03 Athersys, Inc. Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
US8075881B2 (en) 1999-08-05 2011-12-13 Regents Of The University Of Minnesota Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
US8609412B2 (en) 1999-08-05 2013-12-17 Regents Of The University Of Minnesota Mapc generation of lung tissue
US7927587B2 (en) 1999-08-05 2011-04-19 Regents Of The University Of Minnesota MAPC administration for the treatment of lysosomal storage disorders
NZ517002A (en) 1999-08-05 2004-06-25 Mcl Llc Multipotent adult stem cells and methods for isolation
US8252280B1 (en) 1999-08-05 2012-08-28 Regents Of The University Of Minnesota MAPC generation of muscle
US7015037B1 (en) 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
US20030161817A1 (en) 2001-03-28 2003-08-28 Young Henry E. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
DE60041821D1 (en) 1999-09-24 2009-04-30 Cybios Llc PLURIPOTENT EMBRYONAL STEM CELL-SIMILAR CELLS, COMPOSITIONS, AND ITS CONDITIONS
AU7611500A (en) 1999-09-24 2001-04-24 Abt Holding Company Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
EP1257282A4 (en) 1999-12-06 2003-05-02 Gen Hospital Corp Pancreatic stem cells and their use in transplantation
AU3869501A (en) 2000-02-26 2001-09-03 Artecel Sciences Inc Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
AU2001284695A1 (en) 2000-07-31 2002-02-13 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US7560280B2 (en) 2000-11-03 2009-07-14 Kourion Therapeutics Gmbh Human cord blood derived unrestricted somatic stem cells (USSC)
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
EP2305795B1 (en) 2000-12-06 2019-07-03 Celularity, Inc. Method of collecting placental stem cells
EP2336300B1 (en) 2001-02-14 2015-07-08 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
EP1491093B1 (en) 2001-02-14 2013-07-31 ABT Holding Company Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US7056738B2 (en) 2001-03-23 2006-06-06 Tulane University Early stage multipotential stem cells in colonies of bone marrow stromal cells
KR100449141B1 (en) 2001-04-19 2004-09-21 (주)라이프코드 Method for differentiating a mesenchymal stem cell into neural cells
ES2328460T3 (en) 2001-04-24 2009-11-13 Dolores Baksh POPULATIONS OF PROGENITING CELLS, EXPANSION OF THE SAME AND GROWTH OF TYPES OF NON HEMATOPOYETIC CELLS AND FABRICS FROM THE SAME.
US20030003090A1 (en) 2001-05-31 2003-01-02 Prockop Darwin J. Directed in vitro differentiation of marrow stromal cells into neural cell progenitors
US9969980B2 (en) 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
JP2005515777A (en) 2002-01-25 2005-06-02 ジェンザイム・コーポレーション Serum-free medium for chondrocytes and use thereof
WO2004050859A2 (en) 2002-11-27 2004-06-17 Regents Of The University Of Minnesota Homologous recombination in multipotent adult progenitor cells
CA2784829C (en) 2003-04-01 2015-10-06 United States Of America Department Of Veteran's Affairs Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
US20040235165A1 (en) 2003-05-19 2004-11-25 Darwin Prockop In vitro differentiation of adult stem cells
WO2005003317A2 (en) 2003-07-01 2005-01-13 Regents Of The University Of Minnesota Engineered blood vessels
WO2005003320A2 (en) 2003-07-02 2005-01-13 Regents Of The University Of Minnesota Neuronal differentiation of stem cells
EP1660644A1 (en) 2003-08-29 2006-05-31 Regents Of The University Of Minnesota Kidney derived stem cells and methods for their isolation, differentiation and use
US7794706B2 (en) 2003-10-14 2010-09-14 Medivas, Llc Bioactive wound dressings and implantable devices and methods of use
JP2007513188A (en) 2003-12-04 2007-05-24 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ Compositions and methods for the treatment of lysosomal storage diseases
DK1725656T3 (en) 2004-03-05 2014-01-13 John E Davies Serum-free suspension culture system for mesenchymal progenitor cells
JP2007530543A (en) 2004-03-22 2007-11-01 オシリス セラピューティクス，インコーポレイテッド Mesenchymal stem cells and use thereof
EP1737947B9 (en) 2004-04-21 2012-04-25 Regents Of The University Of Minnesota Mapc generation of lung tissue
WO2006047743A2 (en) 2004-10-26 2006-05-04 Regents Of The University Of Minnesota Swine multipotent adult progenitor cells
KR100593397B1 (en) 2004-10-27 2006-06-28 한국원자력연구소 Wound healing or wound healing promoters containing mesodermal stem cells and / or P substances, or cell therapeutics
CA2597757C (en) 2005-02-10 2016-06-28 Regents Of The University Of Minnesota Vascular/lymphatic endothelial cells
US20080311084A1 (en) 2005-05-05 2008-12-18 Verfaillie Catherine M Mapc Engraftment in the Hematopoietic System
EP1877540A1 (en) 2005-05-05 2008-01-16 Regents Of The University Of Minnesota Use of nk cell inhibition to facilitate persistence of engrafted mhc- i negative cells
WO2007117262A2 (en) 2005-07-29 2007-10-18 Athersys, Inc. Culture of non-embryonic cells at high cell density
WO2007016485A2 (en) 2005-07-29 2007-02-08 Athersys, Inc. Use of a gsk-3 inhibitor to maintain potency of cultured cells
CA2625883A1 (en) 2005-10-14 2007-04-26 Regents Of The University Of Minnesota Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
US11000546B2 (en) 2005-11-09 2021-05-11 Athersys, Inc. Immunomodulatory properties of MAPCs and uses thereof
US10117900B2 (en) 2005-11-09 2018-11-06 Athersys, Inc. MAPC treatment of brain injuries and diseases
US20220118026A1 (en) 2005-11-09 2022-04-21 Abt Holding Company Mapc treatment of brain injuries and diseases
US8871198B2 (en) 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
US20100008890A1 (en) 2006-01-23 2010-01-14 Athersys, Inc. MAPC Therapeutics Without Adjunctive Immunosuppressive Treatment
CA2670497A1 (en) 2006-11-24 2008-05-29 Regents Of The University Of Minnesota Endodermal progenitor cells
EP2167045B1 (en) * 2007-06-08 2017-08-09 University of Virginia Patent Foundation Topical poloxamer formulations for enhancing microvascular flow: compositions and uses thereof
CN101978047A (en) 2008-01-18 2011-02-16 明尼苏达大学董事会 Stem cell aggregates and methods for making and using
NZ602651A (en) 2008-02-29 2014-05-30 Univ New York State Res Found Methods of applying physical stimuli to cells
US20110212062A1 (en) 2008-03-27 2011-09-01 Neostem, Inc. Compositions and methods using stem cells in cutaneous wound healing
CA2723765A1 (en) 2008-05-08 2009-11-12 Coretherapix Slu Multipotent adult stem cell population
US9382514B2 (en) 2008-06-20 2016-07-05 Escape Therapeutics, Inc. Compositions comprising mesenchymal stem cell-derived fibroblasts
US20110293578A1 (en) 2008-09-04 2011-12-01 Case Western Reserve University Use of Stem Cells to Prevent Neuronal Dieback
WO2010049752A1 (en) 2008-10-31 2010-05-06 Katholieke Universiteit Leuven Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells
SG178065A1 (en) 2009-07-21 2012-03-29 Abt Holding Co Use of stem cells to reduce leukocyte extravasation
US20110020293A1 (en) 2009-07-21 2011-01-27 Abt Holding Company Use of Stem Cells to Reduce Leukocyte Extravasation
US20120219572A1 (en) 2009-11-12 2012-08-30 Prockop Darwin J Spheroidal Aggregates of Mesenchymal Stem Cells
CA2781194A1 (en) 2009-11-19 2011-05-26 Regents Of The University Of Minnesota Reducing inflammation using cell therapy
US20150010610A1 (en) 2010-02-18 2015-01-08 Osiris Therapeutics, Inc. Immunocompatible amniotic membrane products
WO2011106476A1 (en) 2010-02-25 2011-09-01 Abt Holding Company Modulation of microglia activation
US20110206647A1 (en) 2010-02-25 2011-08-25 Abt Holding Company Modulation of Angiogenesis
SG10201914001QA (en) 2010-02-25 2020-03-30 Abt Holding Co Modulation of macrophage activation
CN102198156A (en) 2010-03-26 2011-09-28 傅毓秀 Pharmaceutical composition for treatment of skin wound
WO2011143411A1 (en) 2010-05-12 2011-11-17 Abt Holding Company Modulation of splenocytes in cell therapy for traumatic brain injury
SG10201913920PA (en) 2010-05-12 2020-03-30 Abt Holding Co Modulation of splenocytes in cell therapy
WO2011158125A2 (en) 2010-06-17 2011-12-22 Katholieke Universiteit Leuven Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells
US9682105B2 (en) 2010-07-14 2017-06-20 University Of Southern California Methods of promoting wound healing and attenuating contact hypersensitivity with gingiva-derived mesenchymal stem cells
IL207586A0 (en) 2010-08-12 2010-12-30 Omrix Biopharmaceuticals Ltd A fibrin based therapeutic preparation and use thereof
US8609406B2 (en) 2010-08-24 2013-12-17 Regents Of The University Of Minnesota Non-static suspension culture of cell aggregates
EP2670842A2 (en) 2011-01-31 2013-12-11 Katholieke Universiteit Leuven KU Leuven Research & Development Methods for making cells with an extra-embryonic endodermal precursor phenotype
EP2718416B1 (en) 2011-06-06 2019-11-13 Regenesys bvba Expansion of stem cells in hollow fiber bioreactors
EP3795159A1 (en) 2013-04-12 2021-03-24 Houston Methodist Hospital Improving organs for transplantation
AU2014266935B2 (en) 2013-04-30 2020-06-11 Katholieke Universiteit Leuven Cell therapy for myelodysplastic syndromes
WO2014210037A2 (en) 2013-06-24 2014-12-31 University Of Southern California Composition of mesenchymal stem cells
WO2015017772A1 (en) 2013-08-01 2015-02-05 Parcell Laboratories, Llc Stem cell-based preparations and methods for dermal and connective tissue reconstruction and rejuvenation
WO2015031110A2 (en) 2013-08-27 2015-03-05 The Regents Of The University Of California Combination therapy to promote wound healing
US20160069903A1 (en) 2014-09-10 2016-03-10 Fundació Institute De Ciències Foròniques Method for detecting cells
US20160326494A1 (en) 2015-05-05 2016-11-10 Katholieke Universiteit Leuven Methods for Pancreatic Islet Transplantation
WO2017062035A1 (en) 2015-10-09 2017-04-13 Abt Holding Company Methods for enhancing proliferation of t regulatory cells
KR20180102661A (en) * 2016-01-21 2018-09-17 에이비티 홀딩 컴퍼니 Stem cells for wound healing
US20200246390A1 (en) 2019-02-01 2020-08-06 Abt Holding Company Multipotent adult projenitor cells for treatment of ich

Also Published As

Publication number Publication date
US10967006B2 (en) 2021-04-06
AU2016387339A1 (en) 2018-08-23
WO2017127123A1 (en) 2017-07-27
KR20180102661A (en) 2018-09-17
JP2020172536A (en) 2020-10-22
CN108884437A (en) 2018-11-23
NZ745530A (en) 2023-03-31
AU2022211794A1 (en) 2022-08-25
SG11201806245TA (en) 2018-08-30
EP3405566A1 (en) 2018-11-28
EP3405566A4 (en) 2019-07-31
AU2016387339B2 (en) 2022-11-17
US20170209493A1 (en) 2017-07-27
EP3405566B1 (en) 2023-10-18
JP2019506396A (en) 2019-03-07
JP2022163207A (en) 2022-10-25
HK1256413A1 (en) 2019-09-20
US20220031756A1 (en) 2022-02-03
US11918609B2 (en) 2024-03-05
JP6918003B2 (en) 2021-08-11
CA3012330A1 (en) 2017-07-27

Similar Documents

Publication Publication Date Title
EP3518315A4 (en) Wound cell
IL267226A (en) Vaporizer
EP3490622C0 (en) Methods and compositions for wound healing
PT2896395T (en) Formulation for topical wound treatment
GB201712733D0 (en) Methods & cells
GB201518669D0 (en) Wound dressing
HK1245159A1 (en) Decellularized tissue
HK1256413A1 (en) Stem cells for wound healing
PL3288510T3 (en) Wound dressing
GB201701509D0 (en) Pluripotenet stem cells
SG11201607925SA (en) Improved stem cell composition
ZA201707843B (en) Wound dressing
EP3374495A4 (en) Improved methods for tissue fabrication
PL3030232T3 (en) Wound healing via autologous stem cell mobilization
HK1258273A1 (en) Devices for wound closure
ZA201900891B (en) B-cell-mimetic cells
GB201805287D0 (en) Haematoietic stem cell treatment
GB201512582D0 (en) Wound treatment
PL3393415T3 (en) Bandage
GB2542107B (en) Winding former
PL3131572T3 (en) Apc analogue for use in wound healing
PL3507300T3 (en) Wound healing peptide
SG10201403640XA (en) Stem cells
SG11202104087QA (en) Stem cell therapy
GB201816934D0 (en) Stem cells